Medication info
Januvia 25 mg (Sitagliptin Phosphate Hydrate)

Januvia 25 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›32.13mg / 1 tablet
Manufacturer / importer
Chong Kun Dang Pharm.
Appearance
A pink, round, biconvex, film-coated tablet engraved with 221 on one side.
Packaging
28 tablets (14 tablets/PTP x 2)
Approval status
Active

MFDS item code 200710760 · Approved 2007.09.21 · Insurance code 643309560

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment based on renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Importer
Chong Kun Dang Pharm.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

View approved original text

This medication helps improve blood sugar control in patients with type 2 diabetes when combined with dietary and exercise regimens. It can be used alone or in combination with other diabetes treatments. This therapy helps effectively manage blood sugar levels.

How to take

Adult dose

This medicine is administered at a dose of 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment As dosage adjustment based on renal function is necessary, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

Severe allergic reactions may occur after administration of this medication, so if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. During treatment with this medication, symptoms of acute pancreatitis may occur, so if severe abdominal pain or vomiting occurs, seek medical attention immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also not be administered to individuals who are allergic to this medication or any of its ingredients. Patients with deteriorated kidney function may need dosage adjustments, so if there is kidney disease, be sure to consult a doctor. Symptoms of hypoglycemia may occur during treatment with this medication, and the risk of hypoglycemia may increase, especially when used in conjunction with insulin or sulfonylureas, therefore blood sugar should be monitored periodically and symptoms should be closely observed. This medication may cause side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea, nausea, etc. If symptoms are severe, consult a doctor. If severe joint pain or the appearance of blisters on the skin occurs, discontinue use immediately and seek medical advice from a specialist. Pregnant or nursing women are advised to avoid using this medication, and safety and efficacy have not been established in children under 18 years of age. Elderly patients may have decreased kidney function, so kidney function should be tested regularly before and during treatment.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory tract infection
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • arthritis with severity and disability
  • blistering pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container that is airtight, and it is recommended to keep it at room temperature between 1 degree and 25 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and ensure its safe use.

Appearance and packaging

Appearance

A pink, round, biconvex, film-coated tablet engraved with 221 on one side.

Package unit

28 tablets (14 tablets/PTP x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.